Amphetamine
- Product NDC
- 0480-3319
- 11-digit product format
- 004803319
- Labeler code
- 0480
- Product ID
- 0480-3319_4373ba4a-1fee-46df-bba9-b60e42cfd15a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amphetamine
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA209253
- Marketing category
- ANDA
- Marketing start
- 2025-12-08
- Substance
- AMPHETAMINE
- Active strength
- 15.7 mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209253-001 | AMPHETAMINE | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | |
| A209253-002 | AMPHETAMINE | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | |
| A209253-003 | AMPHETAMINE | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | |
| A209253-004 | AMPHETAMINE | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | |
| A209253-005 | AMPHETAMINE | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | |
| A209253-006 | AMPHETAMINE | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209253-001 | AB |
| A209253-002 | AB |
| A209253-003 | AB |
| A209253-004 | AB |
| A209253-005 | AB |
| A209253-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-005 | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-006 | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-005 | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-006 | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-005 | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-006 | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | 2023-06-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209253-005 | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209253-006 | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209253-005 | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209253-006 | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209253-005 | AMPHETAMINE | EQ 15.7MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209253-006 | AMPHETAMINE | EQ 18.8MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209253-001 | AMPHETAMINE | EQ 3.1MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209253-002 | AMPHETAMINE | EQ 6.3MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209253-003 | AMPHETAMINE | EQ 9.4MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209253-004 | AMPHETAMINE | EQ 12.5MG BASE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | 2023-06-22 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209253-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209253-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209253-006 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209253-006 | AB | 1 | 6a471c1ec25d… |
| 2023-12-20 04:57 UTC | 2023-12 | A209253-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209253-002 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209253-003 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209253-004 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209253-005 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209253-006 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209253-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209253-002 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209253-003 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209253-004 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209253-005 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209253-006 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209253-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209253-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209253-003 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209253-004 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209253-005 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209253-006 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209253-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209253-002 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209253-003 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209253-004 | AB | 1 | a67488948f0b… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Amphetamine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| AMPHETAMINE | 15.7 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| CK833KGX7E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 243e88e7-6621-47e9-8d5c-3f79bcb088bb | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0f66b30d-6b15-4b2d-91a5-1531b9bb6d21 | Product name | 7 | 20250625 |
| 917bdf48-c3f5-4a58-ac8e-d2d94a9c1e2b | Product name | 2 | 20250616 |
| 8b92ab59-8b26-4c89-a2d6-8d5140526ec6 | Product name | 3 | 20231213 |
| 4496d022-9224-4ee0-943a-50fbe6cd7123 | Product name | 2 | 20220901 |
| 2a7aa275-a4ca-44eb-971f-47427a374085 | Product name | 9 | 20220615 |
| 93730fbf-8b45-4623-b27d-cf03825d04b3 | Product name | 5 | 20220314 |
| 57953747-955c-4dd8-9164-49d8ea877eae | Product name | 1 | 20171113 |
| fcc7ea58-a369-4e91-b092-5cde9ac2669f | Product name | 1 | 20160224 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0480-3319-65 | Amphetamine | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | 2 | |
| 0480-3319-65 | Amphetamine | 30 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0480-3319-65 | EA - Each | 0480-3319 | dc1629f0-075f-4276-aae1-db7b5d106340 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amphetamine | AMPHETAMINE | Teva Pharmaceuticals, Inc. | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 209253 ANDA209253 0480-3319 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1739803 | amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739813 | amphetamine 15.7 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739819 | amphetamine 18.8 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739825 | amphetamine 3.1 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739831 | amphetamine 6.3 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739837 | amphetamine 9.4 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739803 | 24 HR amphetamine 12.5 MG Extended Release Oral Tablet | SCD | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739813 | 24 HR amphetamine 15.7 MG Extended Release Oral Tablet | SCD | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739819 | 24 HR amphetamine 18.8 MG Extended Release Oral Tablet | SCD | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739825 | 24 HR amphetamine 3.1 MG Extended Release Oral Tablet | SCD | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739831 | 24 HR amphetamine 6.3 MG Extended Release Oral Tablet | SCD | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739837 | 24 HR amphetamine 9.4 MG Extended Release Oral Tablet | SCD | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739803 | amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739813 | amphetamine 15.7 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739819 | amphetamine 18.8 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739825 | amphetamine 3.1 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739831 | amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
| 1739837 | amphetamine 9.4 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0480-3319-65 | 00480331965 | 30 BLISTER PACK in 1 CARTON (0480-3319-65) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 30 blister pack | 2025-12-08 | No | No | Current |